YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer >YS
YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer >YS
YS Biopharma將於2024年5月21日舉行特別股東大會並宣佈任命臨時首席執行官 >YS
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊